Elucidation of the DNA repair mechanisms involved in the repair of DNA damage caused by the Arabinosides and Anti-COVID-19 drugs

Rahman, M., Dec 2024
In vitro study showing potential genotoxic side effects of remdesivir and molnupiravir linked to DNA repair pathway deficiencies. Remdesivir incorporation into nascent DNA caused replication fork stalling and acute S-phase arrest in FEN1-deficient cells, impairing Okazaki fragment maturation and amplifying DNA damage. Molnupiravir, which integrates into RNA but requires PARP1, TDP2, BRCA2, and ATM for host DNA repair, exhibited heightened cytotoxicity in cells lacking these factors, suggesting BRCA2-mutated individuals may face elevated risks. Both drugs showed dependency on distinct repair mechanisms, with remdesivir relying on FEN1 for replication fidelity and molnupiravir requiring homologous recombination and BER-independent PARP1 activity. These findings highlight context-dependent risks, particularly in patients with compromised DNA repair pathways, compared to other antivirals with lower genomic integration potential.
Potential risks of molnupiravir include the creation of dangerous variants, and mutagenicity, carcinogenicity, teratogenicity, and embryotoxicity1-15. Multiple analyses have identified variants potentially created by molnupiravir16-20. Studies show significantly increased risk of acute kidney injury21, cardiovascular toxocity22, and neurological symptoms21. Treatment may increase viral rebound23,24.
Study covers molnupiravir and remdesivir.
Rahman et al., 20 Dec 2024, peer-reviewed, 1 author.
Elucidation of the DNA repair mechanisms involved in the repair of DNA damage caused